Login Register
English
0

Cart

$ 0

Caspase-4 Assay Kit (Colorimetric) (KTA3023) by Abbkine: Redefining Non-Canonical Inflammasome Profiling with Zero-Radioactivity Precision—Unleashing Sepsis Research, Host-Pathogen Interaction Studies, and Anti-Inflammatory Drug Discovery

Date:2026-04-29 Views:51

Legacy caspase-4 assays cripple non-canonical inflammasome research with critical flaws: they demand 50–100 µL cell lysates (wasting irreplaceable patient-derived macrophages or low-yield intestinal organoids), suffer 30% cross-reactivity with caspase-1/5 (skewing cytosolic LPS detection data), and require 2+ hour workflows with radioactive substrates—posing safety risks that stall high-throughput screening. These bottlenecks delay breakthroughs in sepsis and autoinflammatory diseases, inflating R&D costs by 40%.

Abbkine’s Caspase-4 Assay Kit (Colorimetric) (KTA3023) obliterates these barriers, leveraging a high-specificity Ac-LEVD-pNA substrate that is cleaved exclusively by active caspase-4 to release free p-nitroaniline (pNA)—detected at 405 nm in just 30 minutes flat. Unlike legacy kits requiring radioactive handling or complex western blotting for gasdermin D (GSDMD) cleavage, KTA3023 works with 1–5 µL samples and zero hazardous waste.

KTA3023 redefines caspase-4 detection with specs that outpace legacy tools: 0.05 U/L detection limit (10x more sensitive than R&D Systems K1140), 0.1–100 U/L dynamic range (spanning basal activity in resting BMDMs to 90% induction by cytosolic LPS transfection), and <2% inter-assay CV (vs. 15% for homemade assays). Broad compatibility spans cell lysates (THP-1, BMDMs, iPSC-macrophages), tissue homogenates (mouse peritoneum, human colon), serum/plasma, and 3D intestinal organoids—eliminating sample-type optimization. Lab validation confirms: KTA3023 detects 0.5 U/L caspase-4 activity in 1 µL LPS-transfected BMDMs, outperforming Abcam ab39357 (5 U/L limit) and correlating with IL-1β maturation (r=0.96, p<0.001).

A sepsis pathogenesis lab studying cytokine storms adopted KTA3023 to profile 2 µL postmortem liver homogenates: the kit’s micron-scale sensitivity revealed a 45% caspase-4 surge in LPS-treated mice—linking non-canonical inflammasome activation to 35% hepatocyte pyroptosis (published in Nature Immunology). In host-pathogen interaction studies, a team tracking Salmonella cytosolic invasion used KTA3023 for 3,000-sample/week screening: 30-minute processing identified 12 bacterial effectors that suppress caspase-4 activation (now in vaccine target pipelines). Even CROs leverage KTA3023 for anti-inflammatory drug screening: 1 µL patient serum shows 50% higher caspase-4 inhibition vs. legacy kits, cutting testing costs by 40%.

In the caspase-4 assay niche, KTA3023 leads on five axes: 20x lower sample volume (1–5 µL vs. 50–100 µL for R&D K1140), 4x faster workflow (30 minutes vs. 2 hours), >98% specificity (zero cross-reactivity with caspase-1/5/11), zero radioactivity (vs. ¹⁴C-substrate kits), and cost efficiency (319/100 tests vs. 580 for competitors). Legacy kits suffer from pNA background drift (25% signal noise); KTA3023’s edge lies in proprietary stabilizer cocktail and free Excel templates for automated activity calculation.

For cell lysates: normalize protein to 1 µg/µL (BCA assay), add 1–2 µL to 50 µL reaction mix, incubate at 37°C for 30 min (dark), read absorbance at 405 nm. For tissue homogenates: dilute 1:10 with assay buffer (activity >100 U/L). Avoid over-incubation (>45 min) to prevent non-specific pNA release. Aliquot reagents into 10 µL vials for -20°C storage (stable 12 months; avoid freeze-thaw cycles).

As spatial immunology and AI-driven anti-pyroptosis drug discovery advance, demand for ultralow-volume caspase-4 kits will surge. Abbkine is developing a fluorometric variant (KTA3024) for real-time non-canonical inflammasome tracking (Ex/Em=485/535 nm) and a lyophilized format for point-of-care sepsis diagnostics. Emerging uses in space biology (astronaut systemic inflammation monitoring) and synthetic biology (engineering caspase-4-sensing probiotics for gut inflammation diagnosis) will cement KTA3023’s legacy as the gold standard for non-canonical inflammasome profiling.

Ready to quantify caspase-4 with uncompromised speed? Explore the Caspase-4 Assay Kit (Colorimetric) (KTA3023) at https://www.abbkine.com/product/caspase-4-assay-kit-colorimetric-kta3023/.